|
- Abemaciclib - Wikipedia
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6
- Abemaciclib for Breast Cancer: Uses, Dosage, Side Effects . . .
Abemaciclib is used to treat HR-positive and HER2-negative breast cancer in adults It is a targeted treatment, not a chemotherapy drug The brand name of abemaciclib is Verzenio
- Abemaciclib (oral route) - Mayo Clinic
Abemaciclib is used together with tamoxifen or an aromatase inhibitor (eg, anastrozole, exemestane, letrozole) to treat hormone receptor (HR)-positive, HER-2 negative, node-positive, early breast cancer with a high risk of coming back as determined by your doctor
- Abemaciclib (Verzenios) - Breast Cancer Now
Abemaciclib is a targeted or biological therapy drug When used to treat breast cancer, abemaciclib is taken alongside hormone (endocrine) therapy Abemaciclib is the drug’s non-branded name Its brand name is Verzenios It belongs to a group of drugs called CDK (cyclin dependent kinase) inhibitors
- Abemaciclib - NCI - National Cancer Institute
Abemaciclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow Blocking these proteins may slow or stop the growth of cancer cells Abemaciclib is a type of targeted therapy drug called a kinase inhibitor
- FDA expands early breast cancer indication for abemaciclib . . .
On March 3, 2023, the Food and Drug Administration (FDA) approved abemaciclib (Verzenio, Eli Lilly and Company) with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant
- Abemaciclib - Chemocare
ABEMACICLIB (a BEM a SYE klib) treats breast cancer It works by blocking a protein that causes cancer cells to grow and multiply This helps to slow or stop the spread of cancer cells
- Abemaciclib: MedlinePlus Drug Information
Abemaciclib is used in combination with tamoxifen (Soltamox) or an aromatase inhibitor such as anastrozole (Arimidex), exemestane (Aromasin), or letrozole (Femara) to treat a certain type of hormone receptor-positive, early breast cancer
|
|
|